CRP and hydrops fetalis: A few studies which examined prognostic value of CRP for HF post-STEMI did not elucidate the question of usefulness of CRP measurement for post-infarct HF over a long-term period [18,19,39]; however, these studies had limitations associated with the use of composite endpoints and guideline-based therapies only in portion of patients, and lacked multiple CRP measurements at various time-points of acute STEMI as well as long-term follow-up.